Skip to main content

Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas.

Publication ,  Conference
Mahadevan, A; Barron, L; Floyd, SR; Kasper, E; Wong, ET
Published in: Journal of Clinical Oncology
May 20, 2015

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

e13036 / e13036

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mahadevan, A., Barron, L., Floyd, S. R., Kasper, E., & Wong, E. T. (2015). Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas. In Journal of Clinical Oncology (Vol. 33, pp. e13036–e13036). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.e13036
Mahadevan, Anand, Loretta Barron, Scott R. Floyd, Ekkehard Kasper, and Eric T. Wong. “Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas.” In Journal of Clinical Oncology, 33:e13036–e13036. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.e13036.
Mahadevan A, Barron L, Floyd SR, Kasper E, Wong ET. Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e13036–e13036.
Mahadevan, Anand, et al. “Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas.Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. e13036–e13036. Crossref, doi:10.1200/jco.2015.33.15_suppl.e13036.
Mahadevan A, Barron L, Floyd SR, Kasper E, Wong ET. Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e13036–e13036.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

e13036 / e13036

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences